Skip to main content

Table 3 Proportion of patients with surgical and nonsurgical pancreatic ductal adenocarcinoma survived for additional time (%)

From: Conditional survival of pancreatic ductal adenocarcinoma in surgical and nonsurgical patients: a retrospective analysis report from a single institution in China

Total survivala Actual survival (CR/PS/NS) Time elapsed after surgery and nonsurgery (CR/PS/NS)
6 months 12 months 18 months 24 months 30 months
6 months 93.7/74.7/35.8     
12 months 77.9/36.8/15.8 83.1/49.3/44.1    
18 months 61.1/13.8/5.8 65.2/18.5/16.2 78.4/37.5/36.7   
24 months 41.1/4.6/1.7 43.9/6.2/4.7 52.8/12.5/10.8 67.3/33.3/29.3  
30 months 22.1/4.6/NA 23.6/6.2/NA 28.4/12.5/NA 36.2/33.3/NA 53.8/NA/NA
36 months 20.0/NA/NA 21.3/NA/NA 25.7/NA/NA 32.7/NA/NA 48.7/NA/NA 90.5/NA/NA
  1. CR curative resection, PS palliative surgery, NS nonsurgery, NA not adopted for all patients died in the subgroup
  2. aIf a patient with curative resection has already survived for 6 months, the 6-month conditional survival is 83.1 %